Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículo Destacado en trastornos del movimiento

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Enfermedad de Parkinson

2053 ARTíCULOS , VIENDO DEL 61 AL 75

PUBMED

Physical therapy interventions for the management of hand tremors in patients with Parkinson's disease: a systematic review

Shahien M, Elaraby A, Gamal M, Abdelazim E, Abdelazeem B, Ghaith HS, Negida A.

Neurol Sci. 2022 Oct 7. doi: 10.1007/s10072-022-06420-1. Online ahead of print.

0

0

0

PUBMED

The Emerging Role of Pericyte-Derived Extracellular Vesicles in Vascular and Neurological Health

Sharma K, Zhang Y, Paudel KR, Kachelmeier A, Hansbro PM, Shi X.

Cells. 2022 Oct 2;11(19):3108. doi: 10.3390/cells11193108.

0

0

0

PUBMED

Transcutaneous Auricular Vagus Stimulation Improves Gait and Reaction Time in Parkinson's Disease

Marano M, Anzini G, Musumeci G, Magliozzi A, Pozzilli V, Capone F, Di Lazzaro V.

Mov Disord. 2022 Oct;37(10):2163-2164. doi: 10.1002/mds.29166. Epub 2022 Jul 21.

0

0

0

PUBMED

Severe distinct dysautonomia in RFC1-related disease associated with Parkinsonism

Record CJ, Alsukhni RA, Curro R, Kaski D, Rubin JS, Morris HR, Cortese A, Iodice V, Reilly MM.

J Peripher Nerv Syst. 2022 Sep 30. doi: 10.1111/jns.12515. Online ahead of print.

0

0

0

PUBMED

Emerging Applications of Electrochemical Impedance Spectroscopy in Tear Film Analysis

Ozdalgic B, Gul M, Uygun ZO, Atçeken N, Tasoglu S.

Biosensors (Basel). 2022 Oct 5;12(10):827. doi: 10.3390/bios12100827.

0

0

0

PUBMED

P75 neurotrophin receptor as a therapeutic target for drug development to treat neurological diseases

Xiong LL, Chen L, Deng IB, Zhou XF, Wang TH.

Eur J Neurosci. 2022 Oct;56(8):5299-5318. doi: 10.1111/ejn.15810. Epub 2022 Sep 7.

0

0

0

PUBMED

Exploring the feasibility of technological visuo-cognitive training in Parkinson's: Study protocol for a pilot randomised controlled trial

Das J, Morris R, Barry G, Vitorio R, Oman P, McDonald C, Walker R, Stuart S.

PLoS One. 2022 Oct 7;17(10):e0275738. doi: 10.1371/journal.pone.0275738. eCollection 2022.

0

0

0

PUBMED

The Neuroprotective Potential of Endophytic Fungi and Proposed Molecular Mechanism: A Current Update

Semwal P, Painuli S, Anand J, Martins NC, Machado M, Sharma R, Batiha GE, Yaro CA, Lorenzo JM, Rahman MM.

Evid Based Complement Alternat Med. 2022 Oct 1;2022:6214264. doi: 10.1155/2022/6214264. eCollection 2022.

0

0

0

PUBMED

Liquid-Liquid Phase Separation Promotes Protein Aggregation and Its Implications in Ferroptosis in Parkinson's Disease Dementia

Li M, Fan Y, Li Q, Wang X, Zhao L, Zhu M.

Oxid Med Cell Longev. 2022 Oct 6;2022:7165387. doi: 10.1155/2022/7165387. eCollection 2022.

0

0

0

PUBMED

Phase 1/1b Studies of UCB0599, an Oral Inhibitor of α-Synuclein Misfolding, Including a Randomized Study in Parkinson's Disease

Smit JW, Basile P, Prato MK, Detalle L, Mathy FX, Schmidt A, Lalla M, Germani M, Domange C, Biere AL, Bani M, Carson S, Genius J.

Mov Disord. 2022 Oct;37(10):2045-2056. doi: 10.1002/mds.29170. Epub 2022 Aug 12.

0

0

0

PUBMED

Motor reserve: How to build neuronal resilience against ageing and neurodegeneration?

Bastos PAD, Barbosa R.

Rev Neurol (Paris). 2022 Oct;178(8):845-854. doi: 10.1016/j.neurol.2021.12.012. Epub 2022 Feb 17.

0

0

0

PUBMED

The kinematic features of hyoid bone movement during swallowing in different disease populations: A narrative review

Wei KC, Hsiao MY, Wang TG.

J Formos Med Assoc. 2022 Oct;121(10):1892-1899. doi: 10.1016/j.jfma.2022.04.007. Epub 2022 Apr 22.

0

0

0

PUBMED

Relationship between thyroid hormones and central nervous system metabolism in physiological and pathological conditions

Sawicka-Gutaj N, Zawalna N, Gut P, Ruchała M.

Pharmacol Rep. 2022 Oct;74(5):847-858. doi: 10.1007/s43440-022-00377-w. Epub 2022 Jun 30.

0

0

0

PUBMED

Using gait robotics to improve symptoms of Parkinson's disease: an open-label, pilot randomized controlled trial

Gryfe P, Sexton A, McGibbon CA.

Eur J Phys Rehabil Med. 2022 Oct;58(5):723-737. doi: 10.23736/S1973-9087.22.07549-9. Epub 2022 Jun 14.

0

0

0

PUBMED

Therapeutic drug repositioning with special emphasis on neurodegenerative diseases: Threats and issues

Kakoti BB, Bezbaruah R, Ahmed N.

Front Pharmacol. 2022 Oct 3;13:1007315. doi: 10.3389/fphar.2022.1007315. eCollection 2022.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy